9h
GlobalData on MSNVertex halts development of diabetes cell therapy after trial failureVertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house ...
Leading Chinese module manufacturer Trinasolar has developed an 808W solar module that uses perovskite/silicon tandem solar ...
The non-profit Institute for Clinical and Economic Review has issued a lukewarm final evidence report on Vertex ...
Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment of Joseph Bolen, Ph.D., as Chief ...
8h
Verywell Health on MSNHow Wernicke-Korsakoff Syndrome Affects the BrainWernicke-Korsakoff syndrome causes memory changes and other neurological symptoms. Learn why it’s underdiagnosed and more ...
Trillions of bacteria occupy human bodies, from head to toe, inside and out, forming a microbiome that is as personal as a ...
18h
Onlymyhealth on MSNThin Appearance Doesn’t Equal Health: Doctor Discusses Visceral Fat Around Organs, Advises Exercises To ReverseIn today’s world, many people think that being thin means being healthy. This belief leads to the idea that if someone looks ...
The musculoskeletal system not only supports bodily functions throughout adulthood but is also integral to health development during the formative years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results